CARL (Carlsmed) ROE % Adjusted to Book Value: -13.63% (As of Mar. 2026)


CARL Carlsmed Inc CARL
12 GF Score
Price $10.39
! 1 Warning Sign
View Full Analysis

What is Carlsmed ROE % Adjusted to Book Value?

Carlsmed CARL -6.65% 12 ROE % Adjusted to Book Value is -13.63% as of Mar. 2026. GuruFocus rates CARL with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Carlsmed's ROE % for the quarter that ended in Mar. 2026 was -36.40%. Carlsmed's PB Ratio for the quarter that ended in Mar. 2026 was 2.67. Carlsmed's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -13.63%.

Carlsmed ROE % Adjusted to Book Value Related Terms

Carlsmed ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Carlsmed's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carlsmed ROE % Adjusted to Book Value Chart

Carlsmed Annual Data
Trend Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 -63.03

Carlsmed Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -86.32 -10.07 -13.63

CARL vs SLP, TBRG, SPOK: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, Carlsmed's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carlsmed ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Carlsmed's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Carlsmed's ROE % Adjusted to Book Value falls into.


CARL
12GF Score
Carlsmed Inc CARL
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carlsmed ROE % Adjusted to Book Value Calculation

Carlsmed's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-209.88% / 3.33
=-63.03%

Carlsmed's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-36.40% / 2.67
=-13.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -13.63% mean?
Carlsmed (CARL) has a ROE % Adjusted to Book Value of -13.63% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Carlsmed and its competitors.
Is Carlsmed's ROE % Adjusted to Book Value too high?
Carlsmed's current ROE % Adjusted to Book Value is -13.63%. Overall, Carlsmed has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Carlsmed's ROE % Adjusted to Book Value compare to SLP and TBRG?
Carlsmed's ROE % Adjusted to Book Value of -13.63% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Carlsmed and its competitors. Carlsmed's current ROE % Adjusted to Book Value is -13.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carlsmed stock overvalued right now?
Carlsmed (CARL) has a current ROE % Adjusted to Book Value of -13.63%. The current ROE % Adjusted to Book Value is -13.63%. Carlsmed's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Carlsmed (CARL), the current ROE % Adjusted to Book Value is -13.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carlsmed Business Description

Other Exchanges I82:Germany
Address 1800 Aston Avenue, Suite 100, Carlsbad, CA, USA, 92008
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
12GF Score

Get the complete analysis for CARL

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.39
Price